“It is not hyperbole to write that there are few scientists who have done as much to advance the health of those infected with hepatitis B virus as Dr. Tyrrell,” Dr. Timothy Block, president of the Hepatitis B Foundation at the Pennsylvania Institute for Hepatitis and Virus Research

Dr. Lorne Tyrrell has helped shape policy in education, health care, and health research. He is the current CIHR/GlaxoSmithKline Chair in Virology at the University of Alberta and the Chief Scientific Officer of KMT, a biotechnology company in Edmonton. Dr. Tyrrell is the Chair of the Board of the Health Quality Council of Alberta, Chair of the Board of the Institute of Health Economics, a Board Member of the Gairdner Foundation.